CYP19A1 and breast cancer: However, according to a survey of the literature, the evaluation of CYP19A1 mRNA by quantitative RT-PCR in the total blood of women with breast cancer recurrence was not reported, but some studies solely involving normal, peritumoral and tumoral tissues are available [11, 18].